Navigation Links
Celleration Inc. Announces Award-Winning Clinical Results to Reduce Unfavorable Deep Tissue Injury Outcomes
Date:3/3/2011

EDEN PRAIRIE, Minn., March 3, 2011 /PRNewswire/ -- Celleration Inc., a privately held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announced the release of award-winning clinical results at the 2011 National Pressure Ulcer Advisory Panel (NPUAP) Biannual meeting in Las Vegas using MIST® Ultrasound Healing Therapy. The clinical results using MIST Therapy to treat deep tissue injuries(DTI), a form of pressure ulcer or bed sore, were so compelling that the poster was awarded NPUAP's top award for contribution to the field of pressure ulcer research.

The retrospective analysis was conducted at Central Baptist Hospital in Lexington, Kentucky and included 85 patients with a total of 127 deep tissue injuries.  The control group received standard of care, while the treatment group added MIST Therapy to the standard of care.  In the MIST Therapy group 80% demonstrated a favorable outcome, while only 22% of the control group demonstrated a favorable outcome. There was a complete reversal of favorable to unfavorable outcomes between the two groups.  Joyce Black, Associate Professor in the College of Nursing at the University of Nebraska Medical Center and Past President of the NPUAP states, "Deep tissue injury is recognized today as the cause of some of the worse pressure ulcers we see. We had come to believe that there was not much we could do to reverse the tissue loss, but the Central Baptist data should cause all of us to rethink our treatments for DTI."

MIST Therapy is a noncontact, low frequency ultrasound that is delivered through a saline mist.  Unlike conventional wound treatments that are limited to treating the surface, MIST Therapy delivers energy deep into the wound bed to rescue injured cells and minimize tissue loss through reducing inflammation and promoting the body's normal healing process.  "We are very pleased with the results of MIST Therapy in treating deep tissue injuries and the ability of MIST to provide a treatment solution where none has previously existed," stated Mark Wagner, CEO of Celleration.  

A deep tissue injury (DTI) is a type of pressure ulcer that results in injury deep below the surface, but is not visible until days later. The injury then progresses very rapidly to a deep, open wound called a Stage III or IV pressure ulcer, which is considered an unfavorable outcome.  DTI's are a common occurrence in US hospitals with average prevalence rates of 7% to 9%.  In 2008, the Center for Medicare Services (CMS) stopped paying for hospital-acquired conditions they felt were the results of poor quality care, commonly known as "never events".  Stage III and IV pressure ulcers, a common outcome of deep tissue injuries, are included on the list of "never events".

For more information go to www.celleration.com


'/>"/>
SOURCE Celleration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Celleration, Inc. Announces Close of $8 Million Series E Financing
2. Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication
3. Kendle Announces Fourth Quarter and Full-Year 2010 Results
4. InstaCare Announces Receipt of Technology and Patent Value Analysis Penned by Joseph Wolf, Ph.D and William Walling, CFA
5. Naviscan Announces European Launch of Positron Emission Mammography
6. CVS Caremark Announces Agreement With ActiveHealth Management for Evidence-Based Clinical Decision Support
7. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
8. Sangamo BioSciences Announces Presentation at the Cowen and Company 31st Annual Health Care Conference
9. An Easier Way to Breathe Better - ICAP Ocean Tomo Announces an Advanced Medical Inhaler Design
10. Perrigo Announces Arrival of the FDA for Reinspection Related to the Allegan Facility Warning Letter
11. Volcano Corporation Announces Webcast of March 9th Analyst Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology:
(Date:6/27/2017)... ... , ... Harbour , a DAO (decentralized autonomous organization) that harnesses the ... their technical specifications . , 2017 has seen an explosion of token launches ... which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, ...
(Date:6/27/2017)... , ... June 27, 2017 , ... A January 18th ... projected to reach a staggering $6.81 billion by the year 2024 according to a ... a faster rate than those made from titanium. Los Angeles area clinic Beverly Hills ...
(Date:6/27/2017)... ... June 27, 2017 , ... Drs. Gregory Toback and ... in Mystic, CT. Covering the process and maintenance strategies of gum grafting and ... periodontal procedures. Drs. Toback and Urbanski practice as experienced periodontists in ...
(Date:6/27/2017)... Los Angeles, CA (PRWEB) , ... June 27, 2017 , ... ... on what crooked bites can indicate about early life experiences. What happens to a ... study reveals that stresses after birth can also take a toll on a baby’s ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced Orthopaedics ... of Richard Robinson as chief operating officer (COO). In this role, Robinson brings ... track record of simplifying business processes and developing growth strategies to increase market ...
Breaking Medicine News(10 mins):